Hero Image

Bristol-Myers Squibb to Acquire Celgene

Sharon Cload, Vice President of Molecular Discovery Technology

The Scientists Behind the Science

Sharon Cload is vice president of Molecular Discovery Technology at our Cambridge, Mass., site.

Building Toward a Translational Future

Building Toward a Translational Future

Saurabh Saha leads the translational medicine team and returns to the Boston-area to build out the new R&D facility in Cambridge.

Emerging Trends in Immuno-Oncology: A Focus on Resistance

Emerging Trends in Immuno-Oncology: A Focus on Resistance

Bristol-Myers Squibb is underwriting a series in partnership with Scientific American, offering expert perspectives on the latest challenges and discoveries in Immuno-Oncology (I-O).

Scientists on the Move

Scientists on the Move

As an R&D footprint expands, several colleagues saw an opportunity to explore new areas of science.  


Hacking R&D: The Role of Artificial Intelligence

Artificial intelligence may have the potential to help scientists solve complex research problems much faster than ever before.

Press Release

Bristol-Myers Squibb and UPSA

Bristol-Myers Squibb announces offer from Taisho Pharmaceutical Holdings Co., Ltd to purchase UPSA.


Standing Together for STEM

Bristol-Myers Squibb rolls out new approach to unify STEM initiatives.

Looking for Answers?

Quick links to helpful resources.

Clinical Trial Information for Researchers

Clinical trials and research are a critical part of bringing new medicines to patients.

Medical Information for Healthcare Providers

Information and resources to assist with caring for patients.

Help Paying for Your Medicines

If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help.